Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:Chemical and Drug Induced Liver Injury
go back to main search page
Accession:DOID:9007383 term browser browse the term
Definition:A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
Synonyms:exact_synonym: Chemically Induced Liver Toxicity;   Drug Induced Acute Liver Injury;   Drug Induced Liver Disease;   Drug Induced Liver Injury;   Drug-Induced Liver Diseases;   Drug-Induced Liver Injuries;   Toxic Hepatitis;   chemically-induced liver toxicities;   hepatotoxicity;   toxic hepatitides
 narrow_synonym: Drug-induced liver injury due to flucloxacillin
 primary_id: MESH:D056486
 alt_id: RDO:0007742
 xref: EFO:0004228;   EFO:0011052;   NCI:C84427


show annotations for term's descendants           Sort by:
Chemical and Drug Induced Liver Injury term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AASS aminoadipate-semialdehyde synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308 		JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 severity
susceptibility		 ISO
IAGP
EXP		 DNA:SNP::2677G>T/A(rs2032582)(human)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832 RGD:11041130, RGD:14700895 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323 		JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 severity IAGP DNA:SNP: :rs2287616(human) RGD PMID:27293027 RGD:14402413 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324 		JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257 		JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility EXP
IAGP
IEP		 CTD Direct Evidence: marker/mechanism
DNA:polymorphism:promoter:-24C>T(human)		 CTD
RGD		 PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354 RGD:14700814, RGD:14700812 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594 		JBrowse link
G ABI1 abl interactor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:26,746,596...26,860,958
Ensembl chr10:26,746,593...26,861,087 		JBrowse link
G ACE angiotensin I converting enzyme ISO mRNA:increased expression:liver (rat) RGD PMID:25143335 RGD:25671447 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380 		JBrowse link
G ACOX3 acyl-CoA oxidase 3, pristanoyl EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:8,355,305...8,440,723
Ensembl chr 4:8,366,282...8,440,723 		JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818 		JBrowse link
G ACTB actin beta ISO
EXP		 mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:25231249 PMID:22563491 RGD:9587759 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902 		JBrowse link
G ACTN4 actinin alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589 		JBrowse link
G ACTR3 actin related protein 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:113,889,934...113,962,596
Ensembl chr 2:113,890,063...113,962,596 		JBrowse link
G ADA adenosine deaminase ISO protein:increased expression:liver RGD PMID:21161045 RGD:5128859 NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252 		JBrowse link
G ADAM8 ADAM metallopeptidase domain 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:24646716 NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868 		JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing EXP CTD Direct Evidence: therapeutic CTD PMID:20709802 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463 		JBrowse link
G ADIPOR2 adiponectin receptor 2 severity ISO associated with obesity, LPS;mRNA:decreased expression:liver (rat) RGD PMID:23838384 RGD:8695926 NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674 		JBrowse link
G ADORA2B adenosine A2b receptor EXP CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746 		JBrowse link
G AGT angiotensinogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:29499335 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576 		JBrowse link
G AHR aryl hydrocarbon receptor EXP
ISO		 CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:decreased expression:liver (rat)		 CTD
RGD		 PMID:21890736 PMID:34848246 PMID:28959666 RGD:401794432 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152 		JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25743375 NCBI chr  X:130,129,362...130,165,841
Ensembl chr  X:130,124,666...130,165,879 		JBrowse link
G AK4 adenylate kinase 4 ISO protein:increased expression:liver (rat) RGD PMID:16538043 RGD:2301096 NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145 		JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 ISO
EXP		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:32805337 PMID:29763686 RGD:27226688 NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049 		JBrowse link
G ALB albumin treatment EXP
ISO		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:18779383 PMID:22310181 PMID:27567545 RGD:14694844 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482 		JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643 		JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member severity
susceptibility		 ISO protein:increased expression:liver
DNA:deletion:exon 3 (mouse)		 RGD PMID:21138988 PMID:30121625 PMID:24492981 RGD:7241599, RGD:15036810, RGD:14975148 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532 		JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562 		JBrowse link
G ALDOB aldolase, fructose-bisphosphate B EXP CTD Direct Evidence: marker/mechanism CTD PMID:16115720 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664 		JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor EXP CTD Direct Evidence: marker/mechanism CTD PMID:18779383 NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328 		JBrowse link
G ANXA2 annexin A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883 		JBrowse link
G ANXA6 annexin A6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:151,100,706...151,157,779
Ensembl chr 5:151,100,706...151,157,815 		JBrowse link
G APOA1 apolipoprotein A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622 		JBrowse link
G APOE apolipoprotein E EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393 		JBrowse link
G APOH apolipoprotein H ISO
EXP		 mRNA:increased expression:plasma:
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:16099942 PMID:23288050 RGD:10054107 NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525 		JBrowse link
G ARG1 arginase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22872058 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332 		JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator EXP CTD Direct Evidence: marker/mechanism CTD PMID:20935161 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708 		JBrowse link
G ATG5 autophagy related 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22491424 NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791 		JBrowse link
G ATOH8 atonal bHLH transcription factor 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383 		JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265 		JBrowse link
G BAD BCL2 associated agonist of cell death treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:17906064 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323 		JBrowse link
G BDKRB2 bradykinin receptor B2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30685357 NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166 		JBrowse link
G BLVRB biliverdin reductase B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764 		JBrowse link
G BMAL1 basic helix-loop-helix ARNT like 1 EXP CTD Direct Evidence: therapeutic CTD PMID:36602574 NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266 		JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:220,057,482...220,089,788
Ensembl chr 1:220,057,482...220,090,462 		JBrowse link
G BRD4 bromodomain containing 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545 		JBrowse link
G BTD biotinidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:15469856 NCBI chr 3:15,601,361...15,722,516
Ensembl chr 3:15,601,341...15,722,311 		JBrowse link
G C3 complement C3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562 		JBrowse link
G CA3 carbonic anhydrase 3 ISO
EXP		 CTD Direct Evidence: marker/mechanism CTD PMID:25226513 PMID:25231249 NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040 		JBrowse link
G CABP1 calcium binding protein 1 ISO protein:increased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr12:120,640,626...120,680,866
Ensembl chr12:120,640,626...120,667,324 		JBrowse link
G CADPS2 calcium dependent secretion activator 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759 		JBrowse link
G CANX calnexin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641 		JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:40,040,240...40,072,648
Ensembl chr 1:40,040,233...40,072,649 		JBrowse link
G CASP8 caspase 8 treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836 		JBrowse link
G CAST calpastatin ISO RGD PMID:16871587 RGD:5683869 NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595
Ensembl chr 5:96,525,267...96,779,595 		JBrowse link
G CAT catalase EXP
ISO		 CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver		 CTD
RGD		 PMID:20623750 PMID:25231249 PMID:21138988 RGD:7241599 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CCDC80 coiled-coil domain containing 80 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 treatment EXP
ISO		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:20623750 PMID:21813474 PMID:30663942 RGD:14995466, RGD:14995458 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CCR2 C-C motif chemokine receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940 		JBrowse link
G CCR5 C-C motif chemokine receptor 5 susceptibility ISO acetaminophen RGD PMID:24770590 RGD:14401733 NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206 		JBrowse link
G CCT3 chaperonin containing TCP1 subunit 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:156,308,968...156,338,292
Ensembl chr 1:156,308,968...156,367,873 		JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389 		JBrowse link
G CDC25B cell division cycle 25B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121 		JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334 		JBrowse link
G CELA1 chymotrypsin like elastase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679 		JBrowse link
G CFAP20 cilia and flagella associated protein 20 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:58,113,592...58,129,381
Ensembl chr16:58,113,592...58,129,381 		JBrowse link
G CFH complement factor H EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476 		JBrowse link
G CHRM3 cholinergic receptor muscarinic 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20197374 NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452 		JBrowse link
G CKB creatine kinase B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833 		JBrowse link
G CLU clusterin EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700 		JBrowse link
G COL14A1 collagen type XIV alpha 1 chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573 		JBrowse link
G COL3A1 collagen type III alpha 1 chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:16679477 NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746 		JBrowse link
G COMT catechol-O-methyltransferase ISO protein:decreased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975 		JBrowse link
G COQ9 coenzyme Q9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:57,447,479...57,461,270
Ensembl chr16:57,447,425...57,461,270 		JBrowse link
G CP ceruloplasmin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829 		JBrowse link
G CPB2 carboxypeptidase B2 ISO mRNA,protein:increased expression,increased activity:liver,plasma RGD PMID:19386599 RGD:7243112 NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033 		JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107 		JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410 		JBrowse link
G CRP C-reactive protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589 		JBrowse link
G CSF3 colony stimulating factor 3 EXP CTD Direct Evidence: therapeutic CTD PMID:20005281 PMID:33882750 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813 		JBrowse link
G CTNNB1 catenin beta 1 EXP CTD Direct Evidence: therapeutic CTD PMID:19679878 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096 		JBrowse link
G CTSE cathepsin E EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909 		JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16118408 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 EXP CTD Direct Evidence: therapeutic CTD PMID:11739529 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G CXCL14 C-X-C motif chemokine ligand 14 EXP CTD Direct Evidence: marker/mechanism CTD PMID:38614205 NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902 		JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 ISO mRNA, protein:decreased expression:kidney (mouse) RGD PMID:26476181 RGD:25671412 NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986 		JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 EXP
ISO		 CTD Direct Evidence: marker/mechanism
CTD Direct Evidence: therapeutic		 CTD PMID:21741958 PMID:23628428 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 PMID:33814510 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G CYP2C18 cytochrome P450 family 2 subfamily C member 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12963435 PMID:28762043 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091 		JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 IAGP DNA:hypermethylation:promoter RGD PMID:27490558 RGD:14700879 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 treatment EXP
ISO
IAGP
IMP		 CTD Direct Evidence: marker/mechanism
DNA:hypermethylation:promoter
associated with Endotoxemia		 CTD
RGD		 PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 More... RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25448281 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898 		JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834 		JBrowse link
G DDB1 damage specific DNA binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596 		JBrowse link
G DGAT2 diacylglycerol O-acyltransferase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535 		JBrowse link
G DHFR dihydrofolate reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:19648163 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983 		JBrowse link
G DHRS7 dehydrogenase/reductase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856 		JBrowse link
G DLAT dihydrolipoamide S-acetyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404 		JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850 		JBrowse link
G DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr10:67,796,669...67,838,188
Ensembl chr10:67,796,669...67,838,188 		JBrowse link
G DSC2 desmocollin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600 		JBrowse link
G E2F1 E2F transcription factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385 		JBrowse link
G ECHDC1 ethylmalonyl-CoA decarboxylase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:127,288,712...127,343,609
Ensembl chr 6:127,288,712...127,343,609 		JBrowse link
G ECHS1 enoyl-CoA hydratase, short chain 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354 		JBrowse link
G EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958 		JBrowse link
G EIF2AK1 eukaryotic translation initiation factor 2 alpha kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25411909 NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175 		JBrowse link
G EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:70,404,145...70,428,618
Ensembl chr10:70,404,145...70,428,618 		JBrowse link
G ENDOG endonuclease G ISO protein:decreased expression:mitochondrion: RGD PMID:22509279 RGD:9685364 NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676 		JBrowse link
G ENG endoglin ISO protein:increased expression:liver (rat) RGD PMID:21146604 RGD:7257529 NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,854,773 		JBrowse link
G ENO1 enolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:25231249 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190 		JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO protein:increased activity:serum: RGD PMID:17850827 RGD:9685426 NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453 		JBrowse link
G EPHX1 epoxide hydrolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563 		JBrowse link
G ERLEC1 endoplasmic reticulum lectin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 2:53,787,044...53,818,796
Ensembl chr 2:53,787,009...53,833,038 		JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30538632 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819 		JBrowse link
G F13A1 coagulation factor XIII A chain ISO RGD PMID:22019897 RGD:11041813 NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013 		JBrowse link
G F2RL3 F2R like thrombin or trypsin receptor 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr19:16,888,999...16,892,606
Ensembl chr19:16,888,999...16,892,606 		JBrowse link
G F3 coagulation factor III, tissue factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22407844 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759 		JBrowse link
G FADD Fas associated via death domain treatment ISO RGD PMID:26062544 PMID:25447754 RGD:11341803, RGD:10053709 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390 		JBrowse link
G FADS1 fatty acid desaturase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318 		JBrowse link
G FADS2 fatty acid desaturase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354 		JBrowse link
G FAS Fas cell surface death receptor ISO protein:increased expression:liver (rat) RGD PMID:16831245 RGD:8662853 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605 		JBrowse link
G FASN fatty acid synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294 		JBrowse link
G FCMR Fc mu receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247 		JBrowse link
G FGA fibrinogen alpha chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742 		JBrowse link
G FGF21 fibroblast growth factor 21 severity ISO mRNA:increased expression:liver (rat) RGD PMID:29883717 RGD:15045603 NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333 		JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 EXP CTD Direct Evidence: therapeutic CTD PMID:21135413 NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145 		JBrowse link
G FMO3 flavin containing dimethylaniline monoxygenase 3 EXP CTD Direct Evidence: therapeutic CTD PMID:24973094 NCBI chr 1:171,090,905...171,117,819
Ensembl chr 1:171,090,901...171,117,819 		JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879 		JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 ISO mRNA:decreased expression:liver (mouse) RGD PMID:28189721 RGD:14695531 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438 		JBrowse link
G G6PD glucose-6-phosphate dehydrogenase treatment ISO RGD PMID:21864513 RGD:10449168 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572 		JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334 		JBrowse link
G GANAB glucosidase II alpha subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,826...62,646,726 		JBrowse link
G GC GC vitamin D binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit ISO
EXP		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:19481141 PMID:17573345 RGD:10402383 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456 		JBrowse link
G GDA guanine deaminase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193 		JBrowse link
G GDI1 GDP dissociation inhibitor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:154,437,154...154,443,467
Ensembl chr  X:154,436,913...154,443,467 		JBrowse link
G GFER growth factor, augmenter of liver regeneration treatment IDA
ISO		 RGD PMID:22033404 PMID:15968720 RGD:9685722, RGD:9685727 NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749 		JBrowse link
G GGH gamma-glutamyl hydrolase EXP CTD Direct Evidence: marker/mechanism CTD PMID:21219404 NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407 		JBrowse link
G GGT1 gamma-glutamyltransferase 1 ISO RGD PMID:10934156 RGD:14701049 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005 		JBrowse link
G GHRL ghrelin and obestatin prepropeptide EXP CTD Direct Evidence: therapeutic CTD PMID:34151639 NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947 		JBrowse link
G GLUD1 glutamate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33483742 NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843 		JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624 		JBrowse link
G GPD1 glycerol-3-phosphate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313 		JBrowse link
G GPT glutamic--pyruvic transaminase treatment EXP
ISO		 CTD Direct Evidence: marker/mechanism
protein:increased expression, activity:serum:		 CTD
RGD		 PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 More... RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174 		JBrowse link
G GPT2 glutamic--pyruvic transaminase 2 ISO protein:increased expression, activity:serum: RGD PMID:19085960 PMID:19085960 RGD:14975249, RGD:14975249 NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289 		JBrowse link
G GRK4 G protein-coupled receptor kinase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:2,963,571...3,040,760
Ensembl chr 4:2,963,571...3,040,760 		JBrowse link
G GSN gelsolin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843 		JBrowse link
G GSR glutathione-disulfide reductase treatment ISO
EXP		 mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663 RGD:7257532, RGD:10401878 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846 		JBrowse link
G GSTA1 glutathione S-transferase alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28412881 NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860 		JBrowse link
G GSTA4 glutathione S-transferase alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304 		JBrowse link
G GSTM1 glutathione S-transferase mu 1 no_association EXP
IAGP
ISO		 CTD Direct Evidence: marker/mechanism
protein:increased expression:liver		 CTD
RGD		 PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 More... RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039 		JBrowse link
G GSTM2 glutathione S-transferase mu 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551 		JBrowse link
G GSTM3 glutathione S-transferase mu 3 EXP CTD Direct Evidence: therapeutic CTD PMID:25743375 NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038 		JBrowse link
G GSTM4 glutathione S-transferase mu 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496 		JBrowse link
G GSTO1 glutathione S-transferase omega 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459 		JBrowse link
G GSTP1 glutathione S-transferase pi 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:25226513 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656 		JBrowse link
G GSTT1 glutathione S-transferase theta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18397238 PMID:18666253 PMID:25226513
G GULOP gulonolactone (L-) oxidase, pseudogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:27,577,611...27,589,073
Ensembl chr 8:27,560,274...27,589,073 		JBrowse link
G H19 H19 imprinted maternally expressed transcript EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr11:1,995,176...2,001,266
Ensembl chr11:1,995,166...2,004,552 		JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:23265463 RGD:8693741 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465 		JBrowse link
G HACL1 2-hydroxyacyl-CoA lyase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 3:15,560,699...15,601,569
Ensembl chr 3:15,560,699...15,601,852 		JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672 		JBrowse link
G HAMP hepcidin antimicrobial peptide ISO mRNA:increased expression:hepatocyte RGD PMID:24373749 RGD:11041724 NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143 		JBrowse link
G HAO2 hydroxyacid oxidase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130 		JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396 		JBrowse link
G HBA1 hemoglobin subunit alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522 		JBrowse link
G HCP5 HLA complex P5 IAGP ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin ClinVar PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,463,180...31,465,809
Ensembl chr 6:31,463,170...31,478,936 		JBrowse link
G HLA-A major histocompatibility complex, class I, A EXP CTD Direct Evidence: marker/mechanism CTD PMID:21570397 PMID:28043905 NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572 		JBrowse link
G HLA-B major histocompatibility complex, class I, B IAGP
EXP		 ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
CTD Direct Evidence: marker/mechanism		 ClinVar
CTD		 PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067 		JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility IAGP DNA:polymorphism: :HLA-DQA1*0102(human)
associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)		 RGD PMID:20639878 PMID:12359646 RGD:14398844, RGD:14401573 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062 		JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 susceptibility EXP
IAGP		 CTD Direct Evidence: marker/mechanism
DNA:polymorphism: :HLA-DQB1*05(human)
DNA:polymorphism, haplotype		 CTD
RGD		 PMID:21570397 PMID:25250564 PMID:26959717 RGD:36174016, RGD:11573514 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383 		JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21570397 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848 		JBrowse link
G HMGB1 high mobility group box 1 treatment EXP
ISO		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:19783637 PMID:29091898 RGD:15090820 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597 		JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO
EXP		 CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD		 PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 RGD:10762620, RGD:15090820 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G HPD 4-hydroxyphenylpyruvate dioxygenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:22872058 NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596 		JBrowse link
G HPRT1 hypoxanthine phosphoribosyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:134,460,165...134,500,668
Ensembl chr  X:134,460,165...134,520,513 		JBrowse link
G HPX hemopexin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617 		JBrowse link
G HRH2 histamine receptor H2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22926047 NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 ISO protein:altered localization:liver (rat) RGD PMID:12376827 RGD:10059389 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615 		JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 severity ISO RGD PMID:31121248 RGD:14985250 NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477 		JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32289347 NCBI chr 8:39,934,651...40,016,392
Ensembl chr 8:39,934,614...40,016,392 		JBrowse link
G IFNA2 interferon alpha 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:1670585 NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398 		JBrowse link
G IFNG interferon gamma EXP
ISO		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:12153990 PMID:21245496 PMID:30013034 RGD:14975100 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IGF1 insulin like growth factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23639586 PMID:25226513 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IL11 interleukin 11 EXP CTD Direct Evidence: therapeutic CTD PMID:11421492 NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463 		JBrowse link
G IL12B interleukin 12B EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863 		JBrowse link
G IL17A interleukin 17A EXP CTD Direct Evidence: marker/mechanism CTD PMID:19633216 PMID:24949944 NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638 		JBrowse link
G IL18 interleukin 18 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19164858 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096 		JBrowse link
G IL1A interleukin 1 alpha EXP CTD Direct Evidence: therapeutic CTD PMID:8218930 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493 		JBrowse link
G IL1B interleukin 1 beta treatment ISO
EXP		 CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD		 PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 More... RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R2 interleukin 1 receptor type 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544 		JBrowse link
G IL22 interleukin 22 EXP CTD Direct Evidence: therapeutic CTD PMID:15122762 PMID:16212920 PMID:23375450 NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604 		JBrowse link
G IL4 interleukin 4 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21094227 PMID:21735453 PMID:22107450 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678 		JBrowse link
G IL6 interleukin 6 treatment EXP
ISO		 CTD Direct Evidence: therapeutic CTD
RGD		 PMID:7532385 PMID:15763341 PMID:29091898 RGD:15090820 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IMMT inner membrane mitochondrial protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472 		JBrowse link
G IRAK1 interleukin 1 receptor associated kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:154,010,507...154,019,902
Ensembl chr  X:154,010,506...154,019,902 		JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506 		JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622 		JBrowse link
G KEAP1 kelch like ECH associated protein 1 ISO RGD PMID:18417483 RGD:6893370 NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558 		JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:12594235 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851 		JBrowse link
G KNG1 kininogen 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:30685357 NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410 		JBrowse link
G KRT18 keratin 18 ISO
EXP		 mRNA, protein:increased expression:liver (mouse)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:19783637 PMID:33483742 PMID:38521541 PMID:17340120 RGD:18337498 NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906 		JBrowse link
G KRT8 keratin 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954 		JBrowse link
G LAP3 leucine aminopeptidase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:17,577,198...17,607,970
Ensembl chr 4:17,577,198...17,607,972 		JBrowse link
G LBP lipopolysaccharide binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013 		JBrowse link
G LCAT lecithin-cholesterol acyltransferase ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131 		JBrowse link
G LCN2 lipocalin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:20623750 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453 		JBrowse link
G LDLR low density lipoprotein receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:36108984 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820 		JBrowse link
G LGALS3 galectin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22461450 NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423 		JBrowse link
G LIPC lipase C, hepatic type ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844 		JBrowse link
G LPL lipoprotein lipase treatment ISO RGD PMID:27071702 RGD:13794380 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259 		JBrowse link
G LRAT lecithin retinol acyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120 		JBrowse link
G LTB4R leukotriene B4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28487374 NCBI chr14:24,311,502...24,318,036
Ensembl chr14:24,311,450...24,318,036 		JBrowse link
G LTF lactotransferrin EXP CTD Direct Evidence: therapeutic CTD PMID:16141546 NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234 		JBrowse link
G MALAT1 metastasis associated lung adenocarcinoma transcript 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073 		JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779 		JBrowse link
G MAP3K5 mitogen-activated protein kinase kinase kinase 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18700144 NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097 		JBrowse link
G MAT1A methionine adenosyltransferase 1A EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658 		JBrowse link
G MCCC1 methylcrotonyl-CoA carboxylase subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:183,015,218...183,116,196
Ensembl chr 3:183,015,218...183,116,075 		JBrowse link
G MDH1 malate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197 		JBrowse link
G ME1 malic enzyme 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MED1 mediator complex subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16109766 NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272 		JBrowse link
G MIR1-1 microRNA 1-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr20:62,554,306...62,554,376
Ensembl chr20:62,554,306...62,554,376 		JBrowse link
G MIR100 microRNA 100 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:122,152,229...122,152,308
Ensembl chr11:122,152,229...122,152,308 		JBrowse link
G MIR103A1 microRNA 103a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 5:168,560,896...168,560,973
Ensembl chr 5:168,560,896...168,560,973 		JBrowse link
G MIR106B microRNA 106b IEP
IDA		 miRNA:decreased expression:liver (rat)
DNA:hypermethylation:promoter		 RGD PMID:29554950 PMID:29554950 RGD:15042854, RGD:15042854 NCBI chr 7:100,093,993...100,094,074
Ensembl chr 7:100,093,993...100,094,074 		JBrowse link
G MIR107 microRNA 107 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr10:89,592,747...89,592,827
Ensembl chr10:89,592,747...89,592,827 		JBrowse link
G MIR10A microRNA 10a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr17:48,579,838...48,579,947
Ensembl chr17:48,579,838...48,579,947 		JBrowse link
G MIR10B microRNA 10b EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:176,150,303...176,150,412
Ensembl chr 2:176,150,303...176,150,412 		JBrowse link
G MIR122 microRNA 122 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 More... NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158 		JBrowse link
G MIR1246 microRNA 1246 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:176,600,980...176,601,052
Ensembl chr 2:176,600,980...176,601,052 		JBrowse link
G MIR1247 microRNA 1247 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:101,560,287...101,560,422
Ensembl chr14:101,560,287...101,560,422 		JBrowse link
G MIR1249 microRNA 1249 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:45,200,954...45,201,019
Ensembl chr22:45,200,954...45,201,019 		JBrowse link
G MIR125B1 microRNA 125b-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:122,099,757...122,099,844
Ensembl chr11:122,099,757...122,099,844 		JBrowse link
G MIR125B2 microRNA 125b-2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,590,237...16,590,325
Ensembl chr21:16,590,237...16,590,325 		JBrowse link
G MIR1260A microRNA 1260a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:77,266,218...77,266,290
Ensembl chr14:77,266,218...77,266,290 		JBrowse link
G MIR1260B microRNA 1260b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:96,341,438...96,341,526
Ensembl chr11:96,341,438...96,341,526 		JBrowse link
G MIR1273H microRNA 1273h EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:24,203,116...24,203,231
Ensembl chr16:24,203,116...24,203,231 		JBrowse link
G MIR1285-1 microRNA 1285-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:92,204,015...92,204,098
Ensembl chr 7:92,204,015...92,204,098 		JBrowse link
G MIR1290 microRNA 1290 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:18,897,071...18,897,148
Ensembl chr 1:18,897,071...18,897,148 		JBrowse link
G MIR1291 microRNA 1291 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:48,654,444...48,654,530
Ensembl chr12:48,654,444...48,654,530 		JBrowse link
G MIR1303 microRNA 1303 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:154,685,776...154,685,861
Ensembl chr 5:154,685,776...154,685,861 		JBrowse link
G MIR1304 microRNA 1304 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:93,733,674...93,733,764
Ensembl chr11:93,733,674...93,733,764 		JBrowse link
G MIR1306 microRNA 1306 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:20,086,058...20,086,142
Ensembl chr22:20,086,058...20,086,142 		JBrowse link
G MIR1307 microRNA 1307 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:103,394,253...103,394,401
Ensembl chr10:103,394,253...103,394,401 		JBrowse link
G MIR130A microRNA 130a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr11:57,641,198...57,641,286
Ensembl chr11:57,641,198...57,641,286 		JBrowse link
G MIR130B microRNA 130b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:21,653,304...21,653,385
Ensembl chr22:21,653,304...21,653,385 		JBrowse link
G MIR132 microRNA 132 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr17:2,049,908...2,050,008
Ensembl chr17:2,049,908...2,050,008 		JBrowse link
G MIR1343 microRNA 1343 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:34,941,837...34,941,920
Ensembl chr11:34,941,837...34,941,920 		JBrowse link
G MIR141 microRNA 141 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191 		JBrowse link
G MIR142 microRNA 142 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318 		JBrowse link
G MIR143 microRNA 143 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023 		JBrowse link
G MIR1468 microRNA 1468 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:63,786,002...63,786,087
Ensembl chr  X:63,786,002...63,786,087 		JBrowse link
G MIR148A microRNA 148a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 7:25,949,919...25,949,986
Ensembl chr 7:25,949,919...25,949,986 		JBrowse link
G MIR149 microRNA 149 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:240,456,001...240,456,089
Ensembl chr 2:240,456,001...240,456,089 		JBrowse link
G MIR150 microRNA 150 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868 		JBrowse link
G MIR151B microRNA 151b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,109,419...100,109,514
Ensembl chr14:100,109,419...100,109,514 		JBrowse link
G MIR152 microRNA 152 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247 		JBrowse link
G MIR155 microRNA 155 treatment ISO RGD PMID:29420849 PMID:26867493 PMID:27673475 RGD:21409750, RGD:25671474, RGD:25671463 NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044 		JBrowse link
G MIR17 microRNA 17 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688 		JBrowse link
G MIR181C microRNA 181c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr19:13,874,699...13,874,808
Ensembl chr19:13,874,699...13,874,808 		JBrowse link
G MIR188 microRNA 188 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,003,503...50,003,588
Ensembl chr  X:50,003,503...50,003,588 		JBrowse link
G MIR18A microRNA 18a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:91,350,751...91,350,821
Ensembl chr13:91,350,751...91,350,821 		JBrowse link
G MIR191 microRNA 191 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:49,020,618...49,020,709
Ensembl chr 3:49,020,618...49,020,709 		JBrowse link
G MIR192 microRNA 192 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106 NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246 		JBrowse link
G MIR193A microRNA 193a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:31,559,996...31,560,083
Ensembl chr17:31,559,996...31,560,083 		JBrowse link
G MIR193B microRNA 193b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049 		JBrowse link
G MIR194-1 microRNA 194-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28844483 NCBI chr 1:220,118,157...220,118,241
Ensembl chr 1:220,118,157...220,118,241 		JBrowse link
G MIR19A microRNA 19a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr13:91,350,891...91,350,972
Ensembl chr13:91,350,891...91,350,972 		JBrowse link
G MIR200C microRNA 200c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:6,963,699...6,963,766
Ensembl chr12:6,963,699...6,963,766 		JBrowse link
G MIR203B microRNA 203b ISO CTD Direct Evidence: therapeutic CTD PMID:32659284 NCBI chr14:104,117,418...104,117,503
Ensembl chr14:104,117,418...104,117,503 		JBrowse link
G MIR21 microRNA 21 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337 		JBrowse link
G MIR210 microRNA 210 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:568,089...568,198
Ensembl chr11:568,089...568,198 		JBrowse link
G MIR217 microRNA 217 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:55,982,967...55,983,076
Ensembl chr 2:55,982,967...55,983,076 		JBrowse link
G MIR218-1 microRNA 218-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:30125006 NCBI chr 4:20,528,275...20,528,384
Ensembl chr 4:20,528,275...20,528,384 		JBrowse link
G MIR22 microRNA 22 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987 		JBrowse link
G MIR221 microRNA 221 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:45,746,157...45,746,266
Ensembl chr  X:45,746,157...45,746,266 		JBrowse link
G MIR222 microRNA 222 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:45,747,015...45,747,124
Ensembl chr  X:45,747,015...45,747,124 		JBrowse link
G MIR223 microRNA 223 ISO RNA:increased expression:serum,liver RGD PMID:28646120 RGD:21408574 NCBI chr  X:66,018,870...66,018,979
Ensembl chr  X:66,018,870...66,018,979 		JBrowse link
G MIR23A microRNA 23a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:13,836,587...13,836,659
Ensembl chr19:13,836,587...13,836,659 		JBrowse link
G MIR23B microRNA 23b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304 		JBrowse link
G MIR27B microRNA 27b EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 9:95,085,445...95,085,541
Ensembl chr 9:95,085,445...95,085,541 		JBrowse link
G MIR29B2 microRNA 29b-2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:207,802,443...207,802,523
Ensembl chr 1:207,802,443...207,802,523 		JBrowse link
G MIR29C microRNA 29c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30515189 NCBI chr 1:207,801,852...207,801,939
Ensembl chr 1:207,801,852...207,801,939 		JBrowse link
G MIR301A microRNA 301a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:59,151,136...59,151,221
Ensembl chr17:59,151,136...59,151,221 		JBrowse link
G MIR30A microRNA 30a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:25359176 PMID:28545106 NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621 		JBrowse link
G MIR30B microRNA 30b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 8:134,800,520...134,800,607
Ensembl chr 8:134,800,520...134,800,607 		JBrowse link
G MIR30C1 microRNA 30c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372 		JBrowse link
G MIR320A microRNA 320a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043 		JBrowse link
G MIR328 microRNA 328 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:67,202,321...67,202,395
Ensembl chr16:67,202,321...67,202,395 		JBrowse link
G MIR335 microRNA 335 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:130,496,111...130,496,204
Ensembl chr 7:130,496,111...130,496,204 		JBrowse link
G MIR337 microRNA 337 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:100,874,493...100,874,585
Ensembl chr14:100,874,493...100,874,585 		JBrowse link
G MIR338 microRNA 338 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:81,125,883...81,125,949
Ensembl chr17:81,125,883...81,125,949 		JBrowse link
G MIR33B microRNA 33b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:17,813,836...17,813,931
Ensembl chr17:17,813,836...17,813,931 		JBrowse link
G MIR342 microRNA 342 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,109,655...100,109,753
Ensembl chr14:100,109,655...100,109,753 		JBrowse link
G MIR345 microRNA 345 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,307,859...100,307,956
Ensembl chr14:100,307,859...100,307,956 		JBrowse link
G MIR34A microRNA 34a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777 		JBrowse link
G MIR34C microRNA 34c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:111,513,439...111,513,515
Ensembl chr11:111,513,439...111,513,515 		JBrowse link
G MIR3591 microRNA 3591 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr18:58,451,080...58,451,152
Ensembl chr18:58,451,080...58,451,152 		JBrowse link
G MIR361 microRNA 361 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:85,903,636...85,903,707
Ensembl chr  X:85,903,636...85,903,707 		JBrowse link
G MIR3615 microRNA 3615 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:74,748,613...74,748,699
Ensembl chr17:74,748,613...74,748,699 		JBrowse link
G MIR362 microRNA 362 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,008,964...50,009,028
Ensembl chr  X:50,008,964...50,009,028 		JBrowse link
G MIR367 microRNA 367 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 4:112,647,874...112,647,941
Ensembl chr 4:112,647,874...112,647,941 		JBrowse link
G MIR378A microRNA 378a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:149,732,825...149,732,890
Ensembl chr 5:149,732,825...149,732,890 		JBrowse link
G MIR378C microRNA 378c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:130,962,588...130,962,668
Ensembl chr10:130,962,588...130,962,668 		JBrowse link
G MIR378I microRNA 378i EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:41,923,222...41,923,297
Ensembl chr22:41,923,222...41,923,297 		JBrowse link
G MIR410 microRNA 410 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:101,065,912...101,065,991
Ensembl chr14:101,065,912...101,065,991 		JBrowse link
G MIR421 microRNA 421 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:74,218,377...74,218,461
Ensembl chr  X:74,218,377...74,218,461 		JBrowse link
G MIR423 microRNA 423 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172 		JBrowse link
G MIR4433B microRNA 4433b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:64,340,747...64,340,848
Ensembl chr 2:64,340,747...64,340,848 		JBrowse link
G MIR4448 microRNA 4448 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:183,886,800...183,886,885
Ensembl chr 3:183,886,800...183,886,885 		JBrowse link
G MIR4492 microRNA 4492 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:118,910,708...118,910,787
Ensembl chr11:118,910,708...118,910,787 		JBrowse link
G MIR4507 microRNA 4507 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:105,858,124...105,858,175
Ensembl chr14:105,858,124...105,858,175 		JBrowse link
G MIR4516 microRNA 4516 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:2,133,119...2,133,204
Ensembl chr16:2,133,119...2,133,204 		JBrowse link
G MIR452 microRNA 452 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:151,959,628...151,959,712
Ensembl chr  X:151,959,628...151,959,712 		JBrowse link
G MIR455 microRNA 455 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:114,209,434...114,209,529
Ensembl chr 9:114,209,434...114,209,529 		JBrowse link
G MIR483 microRNA 483 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209 		JBrowse link
G MIR484 microRNA 484 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372 		JBrowse link
G MIR497 microRNA 497 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:7,017,911...7,018,022
Ensembl chr17:7,017,911...7,018,022 		JBrowse link
G MIR499A microRNA 499a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr20:34,990,376...34,990,497
Ensembl chr20:34,990,376...34,990,497 		JBrowse link
G MIR503 microRNA 503 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:134,546,328...134,546,398
Ensembl chr  X:134,546,328...134,546,398 		JBrowse link
G MIR505 microRNA 505 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:139,924,148...139,924,231
Ensembl chr  X:139,924,148...139,924,231 		JBrowse link
G MIR5196 microRNA 5196 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:35,345,513...35,345,627
Ensembl chr19:35,345,513...35,345,627 		JBrowse link
G MIR532 microRNA 532 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,003,148...50,003,238
Ensembl chr  X:50,003,148...50,003,238 		JBrowse link
G MIR5588 microRNA 5588 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:185,253,210...185,253,272
Ensembl chr 3:185,253,210...185,253,272 		JBrowse link
G MIR574 microRNA 574 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 4:38,868,032...38,868,127
Ensembl chr 4:38,868,032...38,868,127 		JBrowse link
G MIR589 microRNA 589 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:5,495,819...5,495,917
Ensembl chr 7:5,495,819...5,495,917 		JBrowse link
G MIR592 microRNA 592 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr 7:127,058,088...127,058,184
Ensembl chr 7:127,058,088...127,058,184 		JBrowse link
G MIR625 microRNA 625 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:65,471,102...65,471,186
Ensembl chr14:65,471,102...65,471,186 		JBrowse link
G MIR627 microRNA 627 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:42,199,570...42,199,666
Ensembl chr15:42,199,570...42,199,666 		JBrowse link
G MIR629 microRNA 629 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468 		JBrowse link
G MIR651 microRNA 651 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:8,126,965...8,127,061
Ensembl chr  X:8,126,965...8,127,061 		JBrowse link
G MIR660 microRNA 660 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,013,241...50,013,337
Ensembl chr  X:50,013,241...50,013,337 		JBrowse link
G MIR6741 microRNA 6741 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:225,922,080...225,922,142
Ensembl chr 1:225,922,080...225,922,142 		JBrowse link
G MIR6815 microRNA 6815 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:45,478,266...45,478,326
Ensembl chr21:45,478,266...45,478,326 		JBrowse link
G MIR6852 microRNA 6852 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:35,710,676...35,710,741
Ensembl chr 9:35,710,676...35,710,741 		JBrowse link
G MIR744 microRNA 744 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr17:12,081,899...12,081,996
Ensembl chr17:12,081,899...12,081,996 		JBrowse link
G MIR764 microRNA 764 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:114,639,435...114,639,519
Ensembl chr  X:114,639,435...114,639,519 		JBrowse link
G MIR766 microRNA 766 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:119,646,738...119,646,848
Ensembl chr  X:119,646,738...119,646,848 		JBrowse link
G MIR7704 microRNA 7704 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:176,188,843...176,188,901
Ensembl chr 2:176,188,843...176,188,901 		JBrowse link
G MIR7977 microRNA 7977 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:176,515,103...176,515,151
Ensembl chr 3:176,515,103...176,515,151 		JBrowse link
G MIR877 microRNA 877 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27713024 NCBI chr 6:30,584,332...30,584,417
Ensembl chr 6:30,584,332...30,584,417 		JBrowse link
G MIR885 microRNA 885 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:10,394,489...10,394,562
Ensembl chr 3:10,394,489...10,394,562 		JBrowse link
G MIR93 microRNA 93 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847 		JBrowse link
G MIR99A microRNA 99a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,539,089...16,539,169
Ensembl chr21:16,539,089...16,539,169 		JBrowse link
G MIRLET7B microRNA let-7b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768 		JBrowse link
G MIRLET7C microRNA let-7c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,539,828...16,539,911
Ensembl chr21:16,539,828...16,539,911 		JBrowse link
G MIRLET7D microRNA let-7d EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:94,178,834...94,178,920
Ensembl chr 9:94,178,834...94,178,920 		JBrowse link
G MIRLET7G microRNA let-7g EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:52,268,278...52,268,361
Ensembl chr 3:52,268,278...52,268,361 		JBrowse link
G MIRLET7I microRNA let-7i EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769 		JBrowse link
G MMP2 matrix metallopeptidase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15763341 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691 		JBrowse link
G MMP9 matrix metallopeptidase 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561 		JBrowse link
G MST1 macrophage stimulating 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501 		JBrowse link
G MST1R macrophage stimulating 1 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22575169 NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,886,902...49,903,873 		JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 ISO mRNA:decreased expression:blood RGD PMID:20130021 RGD:8657129 NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673 		JBrowse link
G MTHFR methylenetetrahydrofolate reductase treatment EXP
IAGP		 CTD Direct Evidence: marker/mechanism
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)		 CTD
RGD		 PMID:18551038 PMID:19648163 PMID:30545275 RGD:14696733 NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455 		JBrowse link
G MTPN myotrophin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:135,926,760...135,977,359
Ensembl chr 7:135,926,760...135,977,359 		JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor ameliorates ISO RGD PMID:17615358 RGD:150521532 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024 		JBrowse link
G NAT2 N-acetyltransferase 2 treatment IAGP
EXP		 associated with Tuberculosis;DNA:haplotype: :
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090 RGD:8552665 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218 		JBrowse link
G NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:47,579,074...47,584,562
Ensembl chr11:47,565,336...47,584,562 		JBrowse link
G NFATC4 nuclear factor of activated T cells 4 EXP CTD Direct Evidence: therapeutic CTD PMID:34192554 NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO
EXP		 induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD Direct Evidence: therapeutic		 CTD
RGD		 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 More... RGD:6893370, RGD:21201308, RGD:21201305, RGD:21201283, RGD:21201280, RGD:15090820 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 treatment
susceptibility		 ISO
IAGP		 associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) RGD PMID:29091898 PMID:31490979 RGD:15090820, RGD:40902984 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302 		JBrowse link
G NFXL1 nuclear transcription factor, X-box binding like 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:47,847,233...47,914,667
Ensembl chr 4:47,847,233...47,914,667 		JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744 		JBrowse link
G NOTCH1 notch receptor 1 EXP CTD Direct Evidence: therapeutic CTD PMID:30394310 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048 		JBrowse link
G NOX4 NADPH oxidase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 treatment ISO RGD PMID:28522909 PMID:29091898 PMID:28472605 RGD:13439737, RGD:15090820, RGD:13439739 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29943110 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975 		JBrowse link
G NR1D1 nuclear receptor subfamily 1 group D member 1 treatment ISO RGD PMID:24497272 RGD:10448995 NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589 		JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 EXP CTD Direct Evidence: therapeutic CTD PMID:17256725 NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033 		JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 treatment
severity		 EXP
ISO		 CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:liver (rat)
protein:decreased expression:liver (rat)		 CTD
RGD		 PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 More... RGD:15090820, RGD:15045609, RGD:15042870, RGD:14701036, RGD:14701035 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 susceptibility EXP
IAGP		 CTD Direct Evidence: marker/mechanism|therapeutic
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)		 CTD
RGD		 PMID:19797606 PMID:28058446 PMID:31490979 RGD:40902984 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:14742670 PMID:25656644 PMID:28058446 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244 		JBrowse link
G NR2F2 nuclear receptor subfamily 2 group F member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:96,326,046...96,340,263
Ensembl chr15:96,325,938...96,340,263 		JBrowse link
G NR5A2 nuclear receptor subfamily 5 group A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29515023 NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420 		JBrowse link
G NREP neuronal regeneration related protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464 		JBrowse link
G NTN1 netrin 1 EXP CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr17:9,003,087...9,244,000
Ensembl chr17:9,021,510...9,244,000 		JBrowse link
G NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit EXP CTD Direct Evidence: therapeutic CTD PMID:33812996 NCBI chr 6:117,675,469...117,710,727
Ensembl chr 6:117,675,469...117,710,727 		JBrowse link
G OCIAD1 OCIA domain containing 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:48,805,156...48,861,815
Ensembl chr 4:48,805,212...48,861,817 		JBrowse link
G OGDH oxoglutarate dehydrogenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066 		JBrowse link
G OR51E2 olfactory receptor family 51 subfamily E member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854 		JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856 		JBrowse link
G PAH phenylalanine hydroxylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410 		JBrowse link
G PAN2 poly(A) specific ribonuclease subunit PAN2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr12:56,316,936...56,334,000
Ensembl chr12:56,316,223...56,334,053 		JBrowse link
G PANX1 pannexin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29246445 NCBI chr11:94,128,841...94,181,968
Ensembl chr11:94,128,841...94,181,968 		JBrowse link
G PARK7 Parkinsonism associated deglycase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505 		JBrowse link
G PC pyruvate carboxylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386 		JBrowse link
G PCOLCE procollagen C-endopeptidase enhancer EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175 		JBrowse link
G PCYT1A phosphate cytidylyltransferase 1A, choline EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:196,234,368...196,287,726
Ensembl chr 3:196,214,222...196,287,957 		JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21182459 PMID:31809757 NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516 		JBrowse link
G PDLIM5 PDZ and LIM domain 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:94,451,942...94,668,223
Ensembl chr 4:94,451,857...94,668,227 		JBrowse link
G PEX11A peroxisomal biogenesis factor 11 alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:89,681,535...89,690,754
Ensembl chr15:89,677,764...89,690,783 		JBrowse link
G PGM1 phosphoglucomutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245 		JBrowse link
G PLAT plasminogen activator, tissue type EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709 		JBrowse link
G PLG plasminogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097 		JBrowse link
G PLS3 plastin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:115,561,174...115,650,861
Ensembl chr  X:115,561,174...115,650,861 		JBrowse link
G PNP purine nucleoside phosphorylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094 		JBrowse link
G PNRC1 proline rich nuclear receptor coactivator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160 		JBrowse link
G POLG DNA polymerase gamma, catalytic subunit susceptibility
no_association		 EXP
IAGP		 CTD Direct Evidence: marker/mechanism
DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human)
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)		 CTD
RGD		 PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 RGD:15039302, RGD:15039297 NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861 		JBrowse link
G POLR2G RNA polymerase II subunit G EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:62,761,580...62,766,710
Ensembl chr11:62,761,565...62,766,710 		JBrowse link
G PON1 paraoxonase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532 		JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO
EXP		 LPS-induced acute liver damage
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:24385052 PMID:38181850 PMID:21262334 RGD:5509941 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755 		JBrowse link
G PPARG peroxisome proliferator activated receptor gamma ISO mRNA, protein:decreased expression:liver RGD PMID:26599535 RGD:11554658 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356 		JBrowse link
G PPTC7 protein phosphatase targeting COQ7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:110,533,245...110,583,318
Ensembl chr12:110,533,245...110,583,318 		JBrowse link
G PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374 		JBrowse link
G PRKCD protein kinase C delta EXP CTD Direct Evidence: therapeutic CTD PMID:30393195 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717 		JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:21224054 NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178 		JBrowse link
G PTF1A pancreas associated transcription factor 1a EXP CTD Direct Evidence: therapeutic CTD PMID:21182459 NCBI chr10:23,192,312...23,194,245
Ensembl chr10:23,192,312...23,194,245 		JBrowse link
G PTGES2 prostaglandin E synthase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31444509 NCBI chr 9:128,120,693...128,128,440
Ensembl chr 9:128,120,693...128,128,462 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 treatment EXP
ISO		 CTD Direct Evidence: therapeutic CTD
RGD		 PMID:11743745 PMID:29091898 RGD:15090820 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G PUM1 pumilio RNA binding family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:30,931,506...31,065,717
Ensembl chr 1:30,931,506...31,065,991 		JBrowse link
G PYGL glycogen phosphorylase L EXP
IEP		 CTD Direct Evidence: marker/mechanism
protein:increased expression:serum (rat)		 CTD
RGD		 PMID:25231249 PMID:25336395 RGD:21079733 NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483 		JBrowse link
G PZP PZP alpha-2-macroglobulin like EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr12:9,136,472...9,208,395
Ensembl chr12:9,148,840...9,208,395 		JBrowse link
G RASA1 RAS p21 protein activator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,883...87,391,931 		JBrowse link
G RBP1 retinol binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829 		JBrowse link
G RDH13 retinol dehydrogenase 13 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27865848 NCBI chr19:55,039,103...55,069,520
Ensembl chr19:55,039,108...55,071,291 		JBrowse link
G REEP5 receptor accessory protein 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289 		JBrowse link
G RGN regucalcin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:47,078,443...47,093,313
Ensembl chr  X:47,078,355...47,093,314 		JBrowse link
G RIPK3 receptor interacting serine/threonine kinase 3 EXP
ISO		 CTD Direct Evidence: therapeutic
protein:increased expression:liver (mouse)		 CTD
RGD		 PMID:26769846 PMID:28205631 RGD:127229945 NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022 		JBrowse link
G S100A11 S100 calcium binding protein A11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907 		JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO mRNA:increased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668 		JBrowse link
G SELENBP1 selenium binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707 		JBrowse link
G SEMA3A semaphorin 3A EXP CTD Direct Evidence: therapeutic CTD PMID:33290778 NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724 		JBrowse link
G SEMA4A semaphorin 4A EXP CTD Direct Evidence: marker/mechanism CTD PMID:33290778 NCBI chr 1:156,147,373...156,177,744
Ensembl chr 1:156,147,366...156,177,752 		JBrowse link
G SENP2 SUMO specific peptidase 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29535048 NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551 		JBrowse link
G SERPINA1 serpin family A member 1 susceptibility ISO
IAGP		 protein:decreased expression:plasma
DNA:missense mutation:cds:p.E264V(human)		 RGD PMID:11140575 PMID:20170533 RGD:1643168, RGD:14695048 NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693 		JBrowse link
G SERPINA6 serpin family A member 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:94,304,248...94,323,336
Ensembl chr14:94,304,248...94,323,389 		JBrowse link
G SERPINE1 serpin family E member 1 treatment IAGP associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:23183238 RGD:14696750 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247 		JBrowse link
G SERPING1 serpin family G member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171 		JBrowse link
G SESN2 sestrin 2 EXP CTD Direct Evidence: therapeutic CTD PMID:28209544 NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491 		JBrowse link
G SGF29 SAGA complex associated factor 29 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790 		JBrowse link
G SHC1 SHC adaptor protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 PMID:32659284 NCBI chr 1:154,962,298...154,974,376
Ensembl chr 1:154,962,298...154,974,395 		JBrowse link
G SLC10A1 solute carrier family 10 member 1 ISO mRNA:decreased expression:liver (rat) RGD PMID:28827769 RGD:15045609 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241 		JBrowse link
G SLC10A7 solute carrier family 10 member 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372 		JBrowse link
G SLC13A4 solute carrier family 13 member 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:135,681,231...135,728,186
Ensembl chr 7:135,681,231...135,729,258 		JBrowse link
G SLC22A8 solute carrier family 22 member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841 		JBrowse link
G SLC25A29 solute carrier family 25 member 29 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:100,278,567...100,306,444
Ensembl chr14:100,291,116...100,306,547 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 treatment ISO RGD PMID:9200186 RGD:151357001 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507 		JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32259555 NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796 		JBrowse link
G SLPI secretory leukocyte peptidase inhibitor EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564 		JBrowse link
G SNX18 sorting nexin 18 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 5:54,517,759...54,648,005
Ensembl chr 5:54,517,759...54,546,586 		JBrowse link
G SOD1 superoxide dismutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:27349771 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G SOD2 superoxide dismutase 2 treatment
severity
susceptibility		 EXP
IAGP
ISO		 CTD Direct Evidence: marker/mechanism
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human)
DNA:SNP:cds:p.Val16Ala(human)		 CTD
RGD		 PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157 RGD:11060605, RGD:26923961, RGD:26923959, RGD:26923957 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G SOD3 superoxide dismutase 3 EXP CTD Direct Evidence: therapeutic CTD PMID:11529661 NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842 		JBrowse link
G SORD sorbitol dehydrogenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12763371 NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185 		JBrowse link
G SORL1 sortilin related receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763 		JBrowse link
G SPIN2A spindlin family member 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr  X:57,134,265...57,147,180
Ensembl chr  X:57,134,530...57,137,523 		JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532 		JBrowse link
G SRP72 signal recognition particle 72 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: therapeutic CTD PMID:38460807 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568 		JBrowse link
G STAT4 signal transducer and activator of transcription 4 severity ISO protein:increased phosphorylation:liver, inflammatory cell (mouse)
mRNA:increased expression:liver, macrophage (mouse)		 RGD PMID:24731448 PMID:23876342 RGD:25671417, RGD:25671422 NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435 		JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935 		JBrowse link
G SULT1C3 sulfotransferase family 1C member 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351 		JBrowse link
G SULT1E1 sulfotransferase family 1E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145 		JBrowse link
G SULT2B1 sulfotransferase family 2B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27052460 NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425 		JBrowse link
G SUOX sulfite oxidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,997,180...56,006,641 		JBrowse link
G TAGLN2 transgelin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507 		JBrowse link
G TALDO1 transaldolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19436114 NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012 		JBrowse link
G TBXA2R thromboxane A2 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22206755 NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875 		JBrowse link
G TCTN1 tectonic family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr12:110,614,129...110,649,430
Ensembl chr12:110,614,027...110,663,431 		JBrowse link
G TF transferrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641 		JBrowse link
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:27516150 RGD:14995464 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28560358 NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192 		JBrowse link
G THBS1 thrombospondin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:35357534 NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466 		JBrowse link
G THPO thrombopoietin EXP CTD Direct Evidence: therapeutic CTD PMID:33122006 NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968 		JBrowse link
G TLR4 toll like receptor 4 disease_progression ISO RGD PMID:17504260 RGD:14697733 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735 		JBrowse link
G TLR5 toll like receptor 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30508503 NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292 		JBrowse link
G TLR9 toll like receptor 9 severity
treatment		 IEP
ISO		 protein:increased expression: blood, neutrophil (human) RGD PMID:26457748 PMID:19164858 PMID:23509352 RGD:18337465, RGD:18337476, RGD:18337473 NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645 		JBrowse link
G TMED7 transmembrane p24 trafficking protein 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:115,613,210...115,626,036
Ensembl chr 5:115,613,210...115,632,992 		JBrowse link
G TMEM117 transmembrane protein 117 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr12:43,795,802...44,399,108
Ensembl chr12:43,835,967...44,389,762 		JBrowse link
G TMEM164 transmembrane protein 164 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:110,002,369...110,184,251
Ensembl chr  X:110,002,631...110,182,734 		JBrowse link
G TMEM38B transmembrane protein 38B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:105,694,541...105,776,629
Ensembl chr 9:105,694,541...105,776,629 		JBrowse link
G TNF tumor necrosis factor treatment
severity		 ISO
EXP		 CTD Direct Evidence: marker/mechanism|therapeutic
protein:increased expression:serum (rat)		 CTD
RGD		 PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 More... RGD:10450531, RGD:15090820, RGD:15036799, RGD:14995485, RGD:14995437, RGD:14995435, RGD:14995430, RGD:14995429, RGD:14975281, RGD:14696804 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TRAJ18 T cell receptor alpha joining 18 EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr14:22,525,650...22,525,715
Ensembl chr14:22,525,650...22,525,715 		JBrowse link
G TRPM2 transient receptor potential cation channel subfamily M member 2 ISO RGD PMID:24569808 RGD:9999438 NCBI chr21:44,353,621...44,442,644
Ensembl chr21:44,350,163...44,443,081 		JBrowse link
G TTR transthyretin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833 		JBrowse link
G TUBA1A tubulin alpha 1a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324 		JBrowse link
G TUBB4B tubulin beta 4B class IVb EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707 		JBrowse link
G UBA5 ubiquitin like modifier activating enzyme 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 3:132,654,430...132,679,794
Ensembl chr 3:132,654,446...132,679,794 		JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 susceptibility IAGP DNA:SNP:exon (rs4148323)(human) RGD PMID:28900877 RGD:14694824 NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300 		JBrowse link
G UGT1A9 UDP glucuronosyltransferase family 1 member A9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300 		JBrowse link
G UNC93B1 unc-93 homolog B1, TLR signaling regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:67,991,100...68,004,097
Ensembl chr11:67,991,100...68,004,982 		JBrowse link
G USP5 ubiquitin specific peptidase 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,148...6,866,632 		JBrowse link
G VEGFA vascular endothelial growth factor A treatment EXP
IDA		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:25231249 PMID:17784864 RGD:15003197 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
G VIM vimentin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593 		JBrowse link
G VWF von Willebrand factor ISO
EXP		 protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:28527913 PMID:7531171 RGD:11079232 NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770 		JBrowse link
G WASL WASP like actin nucleation promoting factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:123,681,943...123,749,003
Ensembl chr 7:123,681,943...123,749,003 		JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility ISO DNA:haploinsufficiency: : (mouse) RGD PMID:21737425 RGD:15036796 NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473 		JBrowse link
G XYLB xylulokinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:38,346,785...38,453,041
Ensembl chr 3:38,346,760...38,421,348 		JBrowse link
G ZDHHC23 zinc finger DHHC-type palmitoyltransferase 23 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:113,947,901...113,979,508
Ensembl chr 3:113,947,901...113,965,401 		JBrowse link
drug-induced hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility
no_association		 IAGP DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human)
DNA:SNPs:multiple:		 RGD PMID:17502832 PMID:22178260 RGD:14700816, RGD:14700817 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594 		JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO DNA:hypermethylation:promoter RGD PMID:23619520 RGD:14700910 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220 		JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase ISO RGD PMID:16140414 RGD:2316848 NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001 		JBrowse link
G LPAR1 lysophosphatidic acid receptor 1 ISO protein:increased expression:liver (mouse) RGD PMID:12201952 RGD:10054288 NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470 		JBrowse link
G MIR22 microRNA 22 ISO in male; RNA:increased expression:liver: RGD PMID:21750200 RGD:14700876 NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987 		JBrowse link
Halothane Hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GPT glutamic--pyruvic transaminase treatment ISO RGD PMID:28921207 RGD:14975164 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  disease 97543
    Chemically-Induced Disorders 2544
      Poisoning 904
        Chemical and Drug Induced Liver Injury 572
          Halothane Hepatitis 1
          drug-induced hepatitis 5
Path 2
Term Annotations click to browse term
  disease 97543
    disease of anatomical entity 91157
      gastrointestinal system disease 16394
        hepatobiliary disease 4900
          liver disease 4143
            Liver Injury 657
              Chemical and Drug Induced Liver Injury 572
                Halothane Hepatitis 1
                drug-induced hepatitis 5
paths to the root